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Introduction
Tizanidine, 5-Chloro-N-(4, 5-dihydro-1H-imidazol-2-yl)-2, 1, 
3-benzothiadiazol-4-amine, is a new centrally acting skeletal muscle 
relaxant [1]. It is a α2 adrenergic agonist [2] which inhibits spinal reflex 
transmission by descending facilatory pathways and via supraspinal 
inhibitory effects. In addition to its muscle relaxant properties and 
central analgesic effect, it also has gastro protective effect. Hence it 
is used in combination with NSAIDs for the treatment of local pain. 
A survey of literature revealed that various methods are available 
for the estimation of Tizanidine Hydrochloride individually as 
well as simultaneously; these includes HPTLC [3,4], RP-HPLC [5], 
HPLC [6,7], LC-MS [8], Spectrophotometric methods [9-14] but 
none of the spectrophotometric methods has optimized the various 
parameters. Therefore, it was highly desirable to develop a simple 
and robust analytical method that provides satisfactory stability and 
good sensitivity to the complex for routine analysis of Tizanidine 
HCl in dosage forms by using Folin-Ciocalteu (FC) reagent. The FC 
reagent has been used as a chromogen for determination of various 
pharmaceutical agents containing nitrogen [15-21]. The focus of the 
present study was to optimized the concentration of various reagents 
spectrophotometrically, involved in the reaction to form colored 
detectable product by employing 3-factor, 3-level Box-Behnken 
statistical design, and develop robust and simple spectroscopic method 
using previously optimized process parameters.
Material and Methods
Standard Tizanidine HCl was obtained as gift sample from Jackson 
Pharmaceuticals Pvt. Ltd., Amritsar (Punjab). FC reagent was procured 
from Loba Chem. Ltd., Mumbai; Sodium Carbonate was procured 
from S.D Fine and distilled Water (in house production) was used for 
making solutions. Tizan (Sun Pharma) and Sirdalud (Novartis) tablets, 
both containing 2.288 mg of Tizanidine Hydrochloride were procured 
from local market. All UV spectrophotometric measurements were 
recorded using Double beam Jasco V-630 UV spectrophotometer 
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(Jasco V 530, India) with spectral band width of 1.5 nm, wavelength 
accuracy of ± 2 nm and matched quartz cells of 10 mm optical path 
length.
Preparation of standard solution
A definite amount of Tizanidine HCl (10 mg) was transferred to 
a 100 mL volumetric flask. Sufficient quantity of distilled water was 
added and the solution was sonicated for 10 min. Finally, the volume 
was maintained with distilled water to give a final concentration of 100 
µg mL-1. Different sets of working standards at various concentrations 
were prepared by appropriate dilution of the stock solution.
Preparation of derivatizing agent
A working solution of detecting reagent was prepared by dissolving 
20% w/v sodium carbonate solution and 2 N FC reagent diluted with 
two volumes of distilled water. The solution was freshly prepared on 
daily basis for each experiment.
Calibration solution for analysis
Aliquots of (0.4, 0.8, 1.2, 1.6, 2.0, 2.4, 2.8, 3.2 and 3.6 mL) stock 
solution were transferred to a 10 mL of volumetric flask using a 
micropipette. 3 mL of reagent solution were added to each flask and 
heated at 42 ± 2°C for 10 min. Each reaction mixture was cooled at 
room temperature and the volume was made up to mark with distilled 
water to give final concentrations of 4, 8, 12, 16, 20, 24, 28, 32, 36 µg 
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mL-1. The absorbance was measured at 663 nm against a reagent blank. 
The calibration curve was constructed by plotting absorbance versus 
concentration (µg/ml) and correlation coefficient was also measured by 
taking mean of concentrations measured in triplicates.
Sample solution for determination
For the analysis of Tizanidine Hydrochloride in tablets, two 
different commercial brands of 2.288 mg strength (Tizan- Sun Pharma, 
Sirdalud-Novartis) were taken. Twenty tablets each of Tizan and 
Sirdalud were weighed and powdered. The tablets powder equivalent 
to 10 mg of Tizanidine Hydrochloride was accurately weighed for both 
brands and dissolved volumetrically with 100 mL of water by heating at 
42°C to give a concentration of 100 µg mL-1. The flask was cooled and 
the sample was filtered using filter paper (Whatmann). The filtrate (2.5 
mL) was transferred to another 10 mL volumetric flask containing 3 
mL of the reagent solution, heated at 45 ± 5°C for 20 min, volume made 
up to 10 mL with distilled water and analyzed three times and a mean 
of the triplicate measurements was taken.
Validation
Linearity was determined by preparing different concentrations 
of sample solution (4–36 µg mL-1). The precision of the assay was 
determined by repeatability (intra-day) and intermediate precision 
(inter-day). Repeatability was evaluated by assaying samples, at the same 
concentration and during the same day. The intermediate precision was 
studied by comparing the assays on different days (3 days). Three sample 
solutions ranging 8, 16 and 24 µg mL-1 were prepared and analyzed. The 
accuracy of the method was determined as recovery from 20 µg mL-1 
standard solution spiked with 80, 100 and 120% extra Tizanidine HCl. 
Specificity was determined by observing that the placebo samples were 
free from any interfering substances. Placebo samples were prepared by 
dissolving expected ingredients other then drugs in equal proportions 
and then assayed in order to verify that none of the excepients of the 
tablets interfered with the quantity of drugs. Limit of detection (LOD) 
and Limit of Quantification were calculated against blank. All solutions 
were prepared and used in triplicate.
Design
Box-Behnken statistical design was used to optimize the validation 
parameters and systemically investigate the effect of wide range of 
independent and dependent variables. FC reagent concentration (X1), 
sodium bicarbonate concentration (X2) and drug concentration (X3) 
were three independent variables (factors) considered in the method 
development of Tizanidine HCl, while the absorbance was a dependent 
variable (response). Different concentration ranges for FC reagent 
(1.0-10.0 ml), NaHCO3 (1.0-10.0 ml) and drug (4-36 µg mL
-1) were 
selected. The process parameters were studied by conducting the 17 
runs at different levels of all factors. Data collected for responses in 
each run were analyzed using Design Expert 7.1 software (Statease, 
USA) and fitted into a multiple linear regression model.
Results
Optimization of parameters
Folin-Ciocalteu reagent [22] is a commonly used agent for the 
determination of primary amines and amino acids. It reacts with 
groups of Tizanidine HCl in the presence of sodium bicarbonate 
[23,24] to form colored reaction product and it measures the amount 
of the substance needed to inhibit the oxidation of the reagent [25]. 
The reaction conditions were optimized on the basis of maximum 
absorbance by UV-Visible spectrophotometer. 
To identify the optimum levels of different process parameters 
influencing the absorbance, an experimental design of 17 runs 
containing central points was made according to the Box-Behnken 
statistical design for three selected parameters. The individual and 
interactive effects of these process variables were studied by conducting 
the process at different levels of all factors. All the responses observed 
in 17 runs were simultaneously fitted to first order-, second order- and 
quadratic models using Design Expert. It was observed that the best 
fitted model was the quadratic model (results of experimental data and 
simulated values are enlisted in Table 1).
Fitting of data to the model
A three-factor, three-level Box-Behnken statistical experimental 
design as the RSM requires seventeen experiments. The independent 
variables and the response for all seventeen experimental runs are 
given in Table 2. The ranges of Y1 for all batches were 0.200-0.876 
respectively. All the responses observed for seventeen formulations 
were simultaneously fitted to quadratic models using Design Expert® 
(Version 7.1.3, Stat-Ease Inc., and Minneapolis, MN). It was observed 
that the best-fitted model was quadratic model and the comparative 
values of R2, SD and % CV are given in Table 3 along with the regression 
equation generated for each response. All statistically significant 
(p<0.05) coefficients are included in the equations. A positive value 
represents an effect that favors the optimization, while a negative value 
indicates an inverse relationship between the factor and the response. 
It is evident that all the three independent variables viz. the amount of 
Factor  Levels used, Actual (Coded)
  Low (-1) Medium (0) High (+1)
Independent variables
X1=FC-reagent (ml) 1.00 (-1) 5.50 (0)      10.00 (+1)
X2=Sodium carbonate (ml) 1.00 (-1) 5.50 (0) 10.00 (+1)
X3=Drug concentration (µg ml-1) 4.00 (-1) 20.00 (0) 36.00 (+1)
Constraints
Dependant variables
Y1=Absorbance                                                                                                                      
0.200 ≤ Y¬1 ≥ 0.872
Table 1: Variables in Box Behnken design.
Independent Variable Dependent Variables
Runs Batches X1 X2 X3 Y1 (ACTUAL) Y1(PREDICTED) 
1 B1 0 1 -1 0.352 0.67
2 B2 -1 -1 0 0.476 0.24
3 B3 1 1 0 0.621 0.25
4 B4 -1 1 0 0.492 0.23
5 B5 1 -1 1 0.758 0.11
6 B6 0 -1 1 0.675 0.67
7 B7 -1 0 -1 0.201 0.697
8 B8 1 -1 0 0.453 0.23
9 B9 0 0 0 0.432 0.67
10 B10 0 0 0 0.408 0.24
11 B11 0 0 0 0.421 0.24
12 B12 0 1 1 0.871 0.16
13 B13 0 -1 -1 0.286 0.23
14 B14 0 0 0 0.465 0.24
15 B15 -1 0 1 0.568 0.11
16 B16 -1 -1 0 0.432 0.16
17 B17 1 0 -1 0.253 0.20
Table 2: X1=FC Reagent (ml)    X2=Sodium carbonate (ml)    X3=Drug Conc. (µg 
ml-1) Y1=Absorbance.
Citation: Rathee P, Dua K, Rathee S, Kumar V (2014) Statistical Design for Optimization and Determination of Tizanidine Hcl using Folin-
Ciocalteu (Fc) as Chromogenic Reagent. Pharm Anal Acta 5: 307. doi:10.4172/2153-2435.1000307
Page 3 of 5
Volume 5 • Issue 8 • 1000307
Pharm Anal Acta
ISSN: 2153-2435 PAA, an open access journal 
FC-reagent (X1), sodium carbonate (X2) and drug concentration (X3) 
has interactive effects on the response viz. Y1.
Polynomial Equations Analysis





Where Y1 is absorbance, X1 is FC-reagent, X2 is sodium carbonate 
and X3 is the concentration of drug. The Model F-value of 75.70 implies 
the model is significant (P<0.0001). The “Lack of Fit F-value” of 2.42 
implies the Lack of Fit is not significant (P=0.2068). In this case X1, 
X2, X3, X1X2, X1X3, X2X3, X2² are significant model terms and X1X3 and 
X2X3 had a more pronounced effect on absorption than any other 
parameters. The “Pred R-Squared” of 0.8895 is in reasonable agreement 
with the “Adj R-Squared” of 0.9768. “Adeq Precision” measures the 
signal to noise ratio. A ratio greater than 4 is desirable. A ratio of 31.319 
indicates an adequate signal.
Therefore this model can be used to navigate the design space. 
The 2D plots showed the effect of different independent variables on 
absorbance (Y1).
Plots analysis
Two dimensional contour plots were prepared for the response 
(Y1) and are shown in Figure 1a-c respectively. The plots are known 
to study the interaction effects of the factors on the response as well as 
these plots are utile in studying the effects of two factors on the response 
at one time. Interactive effect of X1X2 showed that absorbance increased 
with increasing concentration of either FC-reagent or NaHCO3 at 
constant level. Figure 1b shows that increase in drug concentration 
(X3) from 4 to 36 (μg mL-1) enhances the absorbance (Y1) from 0.078 
to 0.908 with the concentration of FC-reagent (X1). Also the interactive 
effect of X2 and X3 were observed and absorbance was found to increase 
with increasing the concentration of either drug or sodium carbonate 
(Figure 1c).
Method validation
Using the above-optimized parameters, absorption spectra in the 
range (200-600 nm) were obtained for the Tizanidine HCl. Linear 
regression equation was y=0.0239×-0.0591 with mean correlation 
coefficient of 0.9994. Accordingly, the precision of the method was 
determined satisfactorily. The RSD for intra- and inter-day precision 
were in the range of 0.139-0.513% and 0.141–0.987%, respectively. 
The average recovery of the proposed spectrophotometric method 
was 98.5% (RSD=0.57%, SEM=0.119). The method was found to 
be specific as placebo samples did not exhibit any absorption under 
the experimental conditions. LOD and LOQ were found to be 0.207 
and 0.627 μg mL-1, respectively. All the measurements were taken in 
triplicate and mean of readings were used.
Recovery studies
Recovery studies were carried (I.C.H Q2B guidelines) out by 
adding 1, 2 and 3 mg of drug to different samples of tablet powder 
containing the equivalent of 10 mg of drug. From the amount found, 
percentage recovery was calculated. Precision of the method was 
studied by carrying out intraday, interday analysis and expressed as % 
Relative Standard Deviation. The results of recovery studies were found 
to be satisfactory and are reported in Table 4.
Discussion
The mixed acid in the FC reagent involves the following 
















Figure 1a: Contour plot showing the effect of amount of FC-reagent (X1) and 
sodium carbonate (X 2) on response (Y1).
Quadratic model R2 Adjusted R2 Predicted R2 SD % CV
Response (Y1) 0.9898 0.9898 0.9768 0.027 5.58
Regression equations of the fitted quadratic model
Y1=0.34+0.044X1+0.056X2+0.22X3+0.038X1X2+0.035X1X3+0.032X2X3+0.011X1²+0
.090X2² +0.024X3²

















Figure 1b: Contour plot showing the effect of amount of FC-reagent (X1) and 
drug concentration (X 3) on response (Y1).
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P2O5.14WO3.4MoO3.10H2O. Tizanidine Hydrochloride probably 
affects the reduction of 1, 2, or 3 oxygen atoms from tungstate and /
or molybdate in FC reagent (Phosphomolybdo tungstate), thereby 
producing one or more of the possible reduced species which have an 
intense blue color [22]. The proposed method for determination of 
Tizanidine Hydrochloride showed molar absorptivity of 5.642×103 litre 
mole-1 cm-1 and Sandell’s sensitivity of 0.0514 µg/cm2/0.001 absorbance 
units. Linear regression of absorbance on concentration gave the 
equation y=0.0239×-0.0591 with a correlation coefficient (r) of 0.9994. 
Percent relative standard deviation for intraday and interday analysis 
was found to be 0.741 and 0.645 respectively. Limit of detection and 
limit of quantitation were found to be 0.207 and 0.627 respectively. The 
higher percentage recovery value indicates that there is no interference 
of the excipients present in the formulation. This method is useful 
for the determination of Tizanidine Hydrochloride in bulk and 
pharmaceutical formulations.
Concluding Remarks
Tizanidine HCl can be determined in pharmaceutical tablets based 
on reaction with FC reagent in the presence of sodium bicarbonate. 
Simplicity, accuracy and rapidness are a most attractive advantage of 
proposed method. The results obtained confirm the optimization and 
suitability of the proposed methods for the precise analysis and of 
Tizanidine HCl in quality control laboratories.
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Figure 1c: Contour plot showing the effect of amount of sodium carbonate (X2) 
and drug concentration (X 3) on response (Y1).
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